The Relationship between Periodontal Interventions and Healthcare Costs and Utilization. Evidence from an Integrated Dental, Medical, and Pharmacy Commercial Claims Database

Kamyar Nasseh; Marko Vujicic; Michael Glick

doi:10.1002/hec.3316

The Relationship between Periodontal Interventions and Healthcare Costs and Utilization. Evidence from an Integrated Dental, Medical, and Pharmacy Commercial Claims Database

Kamyar Nasseh
, Marko Vujicic
, Michael Glick

Oral Diagnostic Sciences Administration

American Dental Association

Research output: Contribution to journal › Article › peer-review

100 Scopus citations

Abstract

Periodontal disease has been linked to poor glycemic control among individuals with type 2 diabetes. Using integrated dental, medical, and pharmacy commercial claims from Truven MarketScan® Research Databases, we implement inverse probability weighting and doubly robust methods to estimate a relationship between a periodontal intervention and healthcare costs and utilization. Among individuals newly diagnosed with type 2 diabetes, we find that a periodontal intervention is associated with lower total healthcare costs (−$1799), lower total medical costs excluding pharmacy costs (−$1577), and lower total type 2 diabetes-related healthcare costs (−$408).

Original language	English
Pages (from-to)	519-527
Number of pages	9
Journal	Health Economics (United Kingdom)
Volume	26
Issue number	4
DOIs	https://doi.org/10.1002/hec.3316
State	Published - Apr 1 2017

Keywords

doubly robust estimation
healthcare costs and utilization
inverse probability weighting
periodontal intervention
type 2 diabetes

Access to Document

10.1002/hec.3316

Cite this

@article{567639ebaede4a3997289661a9a5bdb0,

title = "The Relationship between Periodontal Interventions and Healthcare Costs and Utilization. Evidence from an Integrated Dental, Medical, and Pharmacy Commercial Claims Database",

abstract = "Periodontal disease has been linked to poor glycemic control among individuals with type 2 diabetes. Using integrated dental, medical, and pharmacy commercial claims from Truven MarketScan{\textregistered} Research Databases, we implement inverse probability weighting and doubly robust methods to estimate a relationship between a periodontal intervention and healthcare costs and utilization. Among individuals newly diagnosed with type 2 diabetes, we find that a periodontal intervention is associated with lower total healthcare costs (−\$1799), lower total medical costs excluding pharmacy costs (−\$1577), and lower total type 2 diabetes-related healthcare costs (−\$408).",

keywords = "doubly robust estimation, healthcare costs and utilization, inverse probability weighting, periodontal intervention, type 2 diabetes",

author = "Kamyar Nasseh and Marko Vujicic and Michael Glick",

note = "Publisher Copyright: {\textcopyright} 2016 The Authors. Health Economics Published by John Wiley \& Sons Ltd.",

year = "2017",

month = apr,

day = "1",

doi = "10.1002/hec.3316",

language = "English",

volume = "26",

pages = "519--527",

journal = "Health Economics (United Kingdom)",

issn = "1057-9230",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

The Relationship between Periodontal Interventions and Healthcare Costs and Utilization. Evidence from an Integrated Dental, Medical, and Pharmacy Commercial Claims Database. / Nasseh, Kamyar; Vujicic, Marko; Glick, Michael.
In: Health Economics (United Kingdom), Vol. 26, No. 4, 01.04.2017, p. 519-527.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The Relationship between Periodontal Interventions and Healthcare Costs and Utilization. Evidence from an Integrated Dental, Medical, and Pharmacy Commercial Claims Database

AU - Nasseh, Kamyar

AU - Vujicic, Marko

AU - Glick, Michael

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Periodontal disease has been linked to poor glycemic control among individuals with type 2 diabetes. Using integrated dental, medical, and pharmacy commercial claims from Truven MarketScan® Research Databases, we implement inverse probability weighting and doubly robust methods to estimate a relationship between a periodontal intervention and healthcare costs and utilization. Among individuals newly diagnosed with type 2 diabetes, we find that a periodontal intervention is associated with lower total healthcare costs (−$1799), lower total medical costs excluding pharmacy costs (−$1577), and lower total type 2 diabetes-related healthcare costs (−$408).

AB - Periodontal disease has been linked to poor glycemic control among individuals with type 2 diabetes. Using integrated dental, medical, and pharmacy commercial claims from Truven MarketScan® Research Databases, we implement inverse probability weighting and doubly robust methods to estimate a relationship between a periodontal intervention and healthcare costs and utilization. Among individuals newly diagnosed with type 2 diabetes, we find that a periodontal intervention is associated with lower total healthcare costs (−$1799), lower total medical costs excluding pharmacy costs (−$1577), and lower total type 2 diabetes-related healthcare costs (−$408).

KW - doubly robust estimation

KW - healthcare costs and utilization

KW - inverse probability weighting

KW - periodontal intervention

KW - type 2 diabetes

UR - https://www.scopus.com/pages/publications/84958073894

U2 - 10.1002/hec.3316

DO - 10.1002/hec.3316

M3 - Article

C2 - 26799518

AN - SCOPUS:84958073894

SN - 1057-9230

VL - 26

SP - 519

EP - 527

JO - Health Economics (United Kingdom)

JF - Health Economics (United Kingdom)

IS - 4

ER -

The Relationship between Periodontal Interventions and Healthcare Costs and Utilization. Evidence from an Integrated Dental, Medical, and Pharmacy Commercial Claims Database

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this